4//SEC Filing
Nuss John 4
Accession 0001193125-25-326892
CIK 0001851194other
Filed
Dec 18, 7:00 PM ET
Accepted
Dec 19, 4:15 PM ET
Size
9.3 KB
Accession
0001193125-25-326892
Insider Transaction Report
Form 4
Nuss John
CHIEF SCIENTIFIC OFFICER
Transactions
- Exercise/Conversion
Common Stock
2025-12-17+34,930→ 502,156 total - Sale
Common Stock
2025-12-18$7.72/sh−12,675$97,840→ 489,481 total - Exercise/Conversion
Restricted Stock Units
2025-12-17−34,930→ 0 total→ Common Stock (34,930 underlying)
Footnotes (4)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of Ventyx Biosciences, Inc. common stock.
- [F2]Represents a broker-assisted sale to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock units.
- [F3]Represents the weighted average share price of an aggregate total of 12,675 shares sold in the price range of $7.595 to $7.85. The reporting owner undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F4]Subject to the reporting person's continuing to be a Service Provider (as defined in the 2021 Equity Incentive Plan) through such applicable vesting date, twenty five percent (25%) of the RSUs subject to the award shall vest on the one (1) year anniversary of the Vesting Commencement Date, and twenty five percent (25%) of the RSUs subject to the award shall vest on each of the next three Vesting Commencement Date anniversaries thereafter. "Vesting Commencement Date" shall mean December 17, 2021.
Documents
Issuer
Ventyx Biosciences, Inc.
CIK 0001851194
Entity typeother
Related Parties
1- filerCIK 0001874108
Filing Metadata
- Form type
- 4
- Filed
- Dec 18, 7:00 PM ET
- Accepted
- Dec 19, 4:15 PM ET
- Size
- 9.3 KB